REG-BARCLAYS PLC FORM 8.3 - WILLIS TOWERS WATSON PLC
04/05/2021 13:25
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210504:nBw99jBfca&default-theme=true
FORM 8.3 - WILLIS TOWERS WATSON PLC
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 03 May 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,700,061 1.32% 165,980 0.13%
(2) Derivatives (other than options):
72,359 0.06% 0 0.00%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,778,520 1.38% 172,080 0.13%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 261.1000 USD
Purchase 1 259.5500 USD
Purchase 2 261.3050 USD
Purchase 3 261.2600 USD
Purchase 12 258.7300 USD
Purchase 20 261.7300 USD
Purchase 37 261.1664 USD
Purchase 57 261.5798 USD
Purchase 62 259.0800 USD
Purchase 80 261.8900 USD
Purchase 100 261.8000 USD
Purchase 100 261.6000 USD
Purchase 100 261.5600 USD
Purchase 111 261.5026 USD
Purchase 115 259.5004 USD
Purchase 127 259.3100 USD
Purchase 200 261.2390 USD
Purchase 214 261.5519 USD
Purchase 556 261.1139 USD
Purchase 603 260.9728 USD
Purchase 750 259.5857 USD
Purchase 820 259.2536 USD
Purchase 1,757 260.0329 USD
Purchase 2,025 260.9885 USD
Purchase 2,392 260.8907 USD
Purchase 2,954 260.3891 USD
Purchase 3,563 259.8644 USD
Purchase 4,100 260.9839 USD
Purchase 4,124 260.9900 USD
Purchase 12,007 260.7429 USD
Purchase 18,568 260.9263 USD
Purchase 34,750 261.2522 USD
Sale 1 260.7200 USD
Sale 1 261.1900 USD
Sale 1 261.8700 USD
Sale 15 261.2000 USD
Sale 100 261.3600 USD
Sale 100 260.9300 USD
Sale 100 261.2200 USD
Sale 100 261.3700 USD
Sale 127 259.3100 USD
Sale 134 261.3649 USD
Sale 150 261.9800 USD
Sale 150 261.4266 USD
Sale 159 260.9671 USD
Sale 200 260.9250 USD
Sale 200 261.0250 USD
Sale 226 261.9640 USD
Sale 300 261.1400 USD
Sale 400 261.2390 USD
Sale 495 261.2708 USD
Sale 500 261.2060 USD
Sale 506 260.6266 USD
Sale 600 261.0291 USD
Sale 726 260.9844 USD
Sale 800 261.0012 USD
Sale 959 261.3550 USD
Sale 1,100 261.0200 USD
Sale 1,112 261.5132 USD
Sale 1,187 261.0838 USD
Sale 1,201 259.8305 USD
Sale 1,247 260.8309 USD
Sale 1,365 261.4413 USD
Sale 1,690 261.1204 USD
Sale 2,065 260.9920 USD
Sale 2,469 260.5199 USD
Sale 2,525 261.3785 USD
Sale 2,752 261.2609 USD
Sale 2,800 260.9403 USD
Sale 3,258 260.9900 USD
Sale 4,191 259.1972 USD
Sale 5,555 260.7813 USD
Sale 7,369 260.7674 USD
Sale 17,567 260.8749 USD
Sale 23,808 261.2296 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 4 May 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210504005790/en/
(https://www.businesswire.com/news/home/20210504005790/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - J.P. Morgan Sec PLC - Stabilisation Notice
AnnouncementREG - Barclays PLC IQE PLC - Form 8.3 IQE PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
AnnouncementREG - Barclays PLC Intertek Group Plc - Form 8.3 INTERTEK GROUP PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
Announcement